Citations 1
N9741: FOLFOX (oxaliplatin(Oxal)/ 5-fluorouracil (5-FU)/ leucovorin (LV) or reduced dose R-IFL (CPT-11 + 5-FU/LV) in advanced colorectal cancer (CRC): Final efficacy data from an intergroup study
Goldberg, Richard M. , Morton, Roscoe F., Fuchs, Charles S. , Ramanathan, R. K., Findlay, B., Pitot, H., Sargent, Daniel J. , Williamson, Stephen K. , Alberts, Steven R.
Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 3621-3621
